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The concept of regulation through complementary idiotypes in an  immunologic 
network includes two essential ideas: (a) complementary responses may be stimulated 
by a  single epitope because the specific products of the idiotypic and anti-idiotypic 
responses are potentially immunogenic, and (b) the products of either complementary 
response can potentially regulate the other response (1, 2). 
Idiotypic and  anti-idiotypic antibody,  and  T  cells  (both  suppressor and  helper) 
have been shown to regulate both humoral and cellular immune responses in vivo 
and in vitro (3-40). Because these reactants can be produced autogenously during the 
course of an  immune response,  it has  been suggested  that  phenomena such as the 
"self-limitation"  of individual  antibody  responses,  the  progressive  decline  in  the 
antibody response after repeated antigen injections, and the oscillation of responses 
after immunization with some kinds of antigens may be due to autoregulation through 
an anti-idiotypic network (5, 7,  19, 31-36, 40). 
Undoubtedly,  the  repertoire of specificities and  the  multiplicity  of functionally 
distinct lymphocyte subpopulations are sufficient to provide the necessary reactants 
for a  complex network.  However, our studies cast doubt on the simple assumption 
that because anti-idiotypic reactants are demonstrable, they are necessarily effective 
mediators of regulation once an antibody response has been stimulated. The reasons 
for doubt are that antibody produced early and rapidly may "tolerize" complementary 
clones, or if complementary reactants do coexist, then the Ig produced may shield or 
protect the clones producing it from the complementary reactants. 
In our model, specific suppression is produced by immunization of A/He mice with 
the phosphorylcholine (PC)l-binding IgA myeloma protein  (T15 idiotype) secreted 
by the plasmocytoma HOPC8 (H8). Such actively immunized mice are unresponsive 
to immunization with PC-containing antigens,  Suppression caused by active immu- 
nization can be reproduced by giving anti-H8 antibody (artS)  passively to normal 
A/He mice. Conversely, A/He mice actively immunized with PC are unresponsive to 
immunization with H8 and this unresponsiveness can be reproduced by giving anti- 
PC antibody (aPC) passively to normal A/He mice (12). Because the antibodies all8 
and 0tPC are directed at least partially against a combining site structure of the other, 
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and because each response can cause reciprocal regulation of the other response, the 
antibodies and corresponding responses are referred to as complementary. 
Although a  prior all8  response suppressed the complementary response and vice 
versa,  neither  complementary  response  was  diminished  when  mice  were  actively 
immunized to have simultaneous complementary responses (12, 24). This absence of 
reciprocal regulation could not be accounted for by a shift in idiotypes or to formation 
of circulating complexes of complementary antibodies (24). Possibly, the complemen- 
tary  antibodies that  were  produced simultaneously  protected  the clones producing 
them  from  reciprocal regulation.  Here we report findings consistent with  this possi- 
bility;  furthermore,  we  show  that  antibody  of  the  specificity  produced  by  the 
suppressed clone can be given passively to rescue the suppressed clone. 
Materials  and  Methods 
Mice.  A/He females, 8-12 wk old, were purchased from Cumberland View Farms, Clinton, 
Tenn. 
Antigens.  The same preparation of formalin-killed vaccine of Diplococcus pneumoniae, R36A, 
was used as in previous studies (12, 24); the vaccine has PC as a major antigenic determinant 
to which mice respond. 2,4,6-trinitrophenyl (TNP)-conjugated N-(2-aminoethyl) carbamylin- 
ethyl Ficoll was prepared and kindly given to us by Dr. Jose Quintans, La Rabida-Universit~ 
of Chicago Institute. Mice were injected intravenously with 0.2 ml of a mixture containing 10 
R36A organisms and 10 pg TNP (PC-TNP). 
A  single  batch  of myeloma  protein  (HS)  produced  by  the  plasmacytoma  HPOC8  in 
BALB/c mice and purified from aseitic fluid (12) was used to immunize mice to produce artS, 
an antibody that is complementary to aPC.  H8 is of the same idiotype (T15)  as the protein 
produced by the plasmacytoma TEPC15.  For active immunization, one part H8,  1.2 mg/ml, 
was homogenized with one part  methylated bovine serum albumin and two parts Freund's 
complete adjuvant; 0.05 ml of the mixture was injected into each hind footpad. Injections of 
H8 in incomplete adjuvant were repeated 1 and 2 wk later. Times reported after immunization 
with H8 were measured after the third injection. 
Plaque-forming Cells (PFC) and Antibody  Titers.  PFC assays and antibody titers (log2) were 
performed as previously described (12, 24), except for the experiment recorded in Table V. In 
this experiment, PFC against PC were assayed in the presence and absence of a  monoclonal 
aT15  reagent  (kindly provided by Dr. John  Kearney, University of Alabama, Birmingham, 
Ala.) to determine the percentage of PFC of T 15 idiotype (39). Data were calculated and results 
were recorded as previously described (24). 
Cultures.  Spleen cells, either unseparated or purified, were cultured as previously reported 
using the modification of the Mishell-Dutton procedure (24). UnseTparated spleen cells treated 
with aThy-l.2 serum were designated as B cells in Table I. 2.5 ×  10  whole spleen eells/ml were 
mixed with 20 pl anti-Thy-l.2 (Litton Bionetics Inc., Kensington, Md.)  per ml of cells. The 
cells were held on ice for 30 rain and were then washed once. 100 pl of complement (Low Tox- 
M  rabbit complement; Accurate Chemical and Scientific Corp., Hicksville, N. Y.) was added 
per 0.9 ml cells; the mixture was incubated at 37°C for 45 min, and the cells were washed once. 
Spleen cells were separated in nylon wool (Fenwal Laboratories, Morton Grove, Ill.) as described 
by Julius  et  al.  (41).  Columns  were  prepared  in  10-ml syringe barrels.  2.0  ml  of medium 
containing l0  s spleen cells was added slowly to the columns, followed by 1.0 ml of medium. 
The columns were incubated for 45 min at 37°C. Cells were washed off the columns by adding 
20  ml  of medium  drop  by  drop.  The  medium  was  Dulbecco's phosphate-buffered  saline 
containing 5% heat-inactivated fetal calf serum.  The purity and functional characteristics of 
the cell preparations were the same as those reported previously from this Institution using 
identical materials and procedures (14, 39). 
Irradiation.  Mice received 300 rad total body irradiation from a 137Cs source at a rate of 200 
rad/min.  When  irradiated  mice  received nylon  wool-purified  (NWP)  cells, the  cells were 
prepared in the same way as for culture. 
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injected in multiple intradermal sites four or five times at weekly intervals with 0.2 ml of H8 in 
adjuvants as previously described (12).  The serum (all8) had an agglutinin titer of 11  to H8- 
sheep erythrocytes (SRBC). Normal mice injected with 0.2 ml all8 had titers of 6-8 the next 
day, titers of 3-5 2 wk later, and 1-3 4 wk later. 
A  pool of primary response serum was prepared from 24 A/He mice immunized with PC 
and bled at 6 d; the serum had an agglutinin titer against PC-coated SRBC of 7. This serum 
was compared with aPC and was used in experiments that are discussed below. 
A culture line of hybridoma cells, designated M2, that secretes IgM aPC of T15 idiotype, 
was kindly supplied by Dr.  Patricia Gearhart, Carnegie Institute of Washington, Baltimore, 
Md. The hybridoma was produced by fusion between spleen cells from a BALB/c mouse and 
cells from the SP 2/0 line (nonsecreting myeloma cells). 106 hybridoma cells grown in culture 
were injected intraperitoneally into each BALB/e mouse that had been injected intraperito- 
neally 2 wk earlier with 0.5 ml Pristine. Ascitic fluid was tapped 10-14 d  later and again one 
or two more times at  3-4-d intervals. The idiotype was confirmed using monoclonal aT15, 
which completely inhibited plaque  formation against  PC-SRBC  using hybridoma cells re- 
covered from ascitic fluid. A pool of 100 ml ascitic fluid was prepared that had an agglutinin 
titer against PC-SRBC of 11. Ascitic fluid, referred to in the text as ~PC, was used for passive 
immunization  in  all experiments reported  here  in  detail, but  before its use,  the  biological 
activity was compared with primary response serum obtained from A/He mice immunized 
with PC, and with aPC purified from the ascitic fluid by absorption and elution from PC- 
Sepharose. The aPC and purified aPC were diluted to have titers of 7, i.e., equivalent to the 
titer of the primary response antisera. The  three  preparations all caused >50%  and  <90% 
suppression to immunization with PC when  given to mice (0.2  ml intravenously/mouse) or 
added to cultures (50/d,  1:10)  at the time of immunization with PC-TNP;  none of the three 
preparations affected the response to TNP. 
Normal mice and irradiated normal mice were injected intraperitoneally with 0.5 ml t~PC 
every other day three times. The mice were bled serially, aPC titers of 6-8 were sustained by 
the injections; when injections were stopped, titers fell to baseline levels by 4 wk after the last 
injection. Titers were equivalent in normal and irradiated mice. 0.5 ml ~tPC given intraperito- 
neally every other day three or four times produced levels of serum antibody that approximated 
levels resulting from active immunization of A/He mice with PC in adjuvants as had been 
done in previous experiments demonstrating simultaneous complementary responses (12). 
Results 
Preliminary Observations.  Normal young adult A/He  mice have no or very low (1-3) 
titers of aPC  and <100 background PFC/spleen to PC-SRBC.  In contrast, BALB/c 
mice usually have background serum titers of 4-7 and as many as  1,000 background 
PFC/spleen. The response of A/He  mice or their spleen cells in culture to immuni- 
zation  with  PC  is  quite  low;  e.g.,  responses  are  usually  10-20%  as  high  as  for 
BALB/c  mice.  Approximately  50%  (individual  variation,  30-70%)  of  PFC  from 
A/He  mice immunized with  PC are of T15  idiotype, compared with 90% or greater 
for BALB/c mice. A/He  mice respond to immunization with T15 or H8 by producing 
high titers of all8, whereas BALB/c mice do not respond unless they have been made 
neonatally tolerant to PC (42). 
A/He  mice  that  have  been  actively immunized  with  H8  (but  not  normal A/He 
mice) develop shock when injected with either 0.2 ml aPC or 0.2 ml A/He  antiserum 
to PC.  Interestingly, in previous studies, aT15  given intravenously to BALB/c mice 
caused  an  identical reaction  that  was considered  to be  anaphylaxis resulting from 
interaction of aT 15 with normally circulating aPC antibodies occurring in this mouse 
strain. The reaction in BALB/c mice was circumvented by giving aT15  intraperito- 
neally  (3);  the  reaction  in  A/He  mice  was  similarly circumvented  in  the  present 
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TABLE  I 
Suppression by a Complementary Response 
In vivo¢  In vitro§  Ex-  Preim-  Challenge 
peri-  muniza-  immuniza- 
ment  tion*  tion  aPC PFC/spleen  aPC PFC/culture 
Whole cells  B cells 
1  None  PC-TNP  t5,000 (4.17 ± 0.21)  319 (2.51 ± 0.11)  168 (2.22 ± 0.08) 
H8  PC-TNP  350 (2.54 ± 0. l 1)  46 (l.66 ± 0.05)  65 (1.81 ± 0.02) 
H8  PC-TNP  200 (2.30 ± 0.13)  28 (1.45 ± 0.02)  26 (1.41 ± 0.05) 
2  None  PC-TNP  6,960 (3.84 + 0.32)  168 (2.22 ± 0.07)  250 (2.40 ± 0.I0) 
all8  PC-TNP  240 (2.38 ± 0.08)  25 (1.39 ± 0.01)  20 (l.30 ± 0.04) 
* In experiment 1, active immunization was completed 1 wk or 6 mo before challenge immunization. In 
experiment 2, all8 (0.2 ml, 1:2) was given 1 wk before challenge immunization. 
:~ Each group contained five or six mice. Differences between the control and the preimmunized groups in 
both experiments were significant, P = < 0.01. The mean numbers of aTNP PFC/spleen for the groups 
in experiment I were 56,000 and 45,000 and 65,000, respectively; and 25,100 and 32,500, respectively, for 
experiment. 2. 
§ Ceils were  pooled  from  two  or three mice  and cultures were  immunized with  PC-TNP. Differences 
between the nonimmunized  and pi'eimmunized groups in both experiments were significant, P = < 0.0l. 
The mean numbers of aTNP PFC/culture in experiment t were 303, 428, and 568 for whole cells; and 
130, 101, and 298 for B cells. In experiment 2, mean numbers were 940 and 1230 for whole cells and 860 
and 860 for B cells. 
During the course of the present work,  previous observations were confirmed. For 
example, A/He  mice immunized  with  H8 were  unresponsive to  immunization  with 
PC  (experiment  1, Table I). In other experiments, mice were immunized  simultane- 
ously with  H8  in adjuvants in one footpad  and with  PC  in adjuvants in the  other 
footpad as previously described (12). Simultaneous aPC  and all8  PFC responses were 
demonstrated  in  corresponding  popliteal  lymph  nodes  assayed  4  d  after  the  third 
immunization, and sera had titers of all8  of 7-10 and aPC  of 5-7. Unseparated cells 
and B cells were prepared for culture from spleens of simultaneously immunized mice 
1 wk and  1 mo after the third immunization. The PFC responses to PC and TNP  of 
both unseparated cells and B cells were as high as for cells obtained from normal mice 
or from mice remotely immunized with PC (data not shown). 
These observations taken together support  previous findings that  a  prior immune 
response  suppresses  the  complementary  response,  but  reciprocal  regulation  is  not 
effective when complementary  responses are simultaneous. But it was indeterminant 
whether  B  cells  from  suppressed  mice  were  reversibly  suppressed  or  were  made 
tolerant .2 
Elimination of Cells Responsive to PC and the Apparent Absence of Suppressor Cells.  Mice 
or  spleen  cells  from  mice  recently  or  remotely  actively  immunized  with  H8  were 
immunized  with  PC.  As  shown  in  Table  I,  experiment  1,  both  mice  and  cells  in 
culture were  unresponsive to  PC  but  responded  normally to  TNP.  The  absence of 
response of unseparated cells in culture might be due to suppression by T  cells and/ 
or all8  secreted by B  lymphocytes. However, purified B  cells were unresponsive, and 
spleen cells from mice immunized with H8 as in this experiment do not contain PFC 
to  H8-coated  SRBC  (12),  and  do  not suppress  when  cocultured  with  normal  cells 
2 For convenience, we assume that cells made tolerant are eliminated, although it is possible that the 
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NWP cells from 
Normal cells  Mice immunized  aPC PFC/cuhure~: 
Normal mice  with H8* 
107  340  (2.53 2: 0.09) 
5 X l0  n  250  (2.40 2: 0.04) 
5 X 10  s  5 X 106  240  (2.38 2: 0.06) 
5 X l0  s  5 X 106  310  (2.49 2: 0.08) 
107  <50  -- 
107  <50  -- 
10  v  Normal serum  450 
l07  Serum from mice im-  <50  -- 
munized with H8 
* Mice were actively immunized with H8 1 mo earlier. Serum pooled from normal or immunized mice was 
added to cultures in a final dilution of 1:200. 
Cultures were immunized with PC-TNP. Responses of cultures of normal cells with added NWP cells 
were not significantly different. All cultures of normal cells, with or without added NWP cells or serum, 
contained 900-1,300  PFC to TNP. 
(data  not shown).  Furthermore,  as shown in Table  I, experiment  2, purified  B  cells 
from mice passively immunized  1 wk earlier with all8  are also unresponsive. 
In additional experiments of similar design, the responses of spleen cells obtained 
1 or 4  d  after mice received all8  were reduced by -40  and 80%, respectively. Thus, 
the effect of all8  in vivo on cells responsive to PC in vitro must be quite rapid, but 
cumulative for several days. 3 Together the observations indicate that  B  lymphocytes 
responsive  to  PC  are  made  tolerant  by  active  immunization  with  H8  or  passive 
immunization  with artS,  a  conclusion consistent with earlier studies showing that  a 
xenogeneic anti-idiotypic antiserum eliminated idiotypic cell precursors responsive to 
group A  streptococci  (4). 
In attempts to determine whether spleens of suppressed mice contained suppressor 
cells, whole cells or NWP  cells were prepared from mice, recently or remotely actively 
immunized with H8 or passively immunized with artS.  In different experiments, the 
cells were added in various numbers to cultures of either whole spleen cells or purified 
splenic B  cells obtained from normal  mice. The  results recorded  for one experiment 
(Table II) were typical for this type of experiment in that NWP cells from unresponsive 
mice either did not suppress or caused no more suppression than NWP  cells obtained 
from  normal  mice.  In contrast  to  the  ineffectiveness of cells, serum  from  the  mice 
actively immunized  with  H8 caused  marked  suppression of responses to  PC  and no 
suppression of responses to TNP. 
Immature  or  regenerating  B  cells  are  inactivated  or  are  "made  tolerant"  more 
readily by antigen or anti-idiotypic antibody (43-52)  than mature B  cells. Therefore, 
we  tested  whether cells from suppressed  mice inhibited regeneration of aPC  respon- 
sivity in sublethally irradiated  mice. Unseparated  or NWP  cells obtained from  mice 
a Spleen  cells obtained from young adult BALB/c mice 1-4 d after receiving all8 (aT15)  responded 
normally in culture, although cells obtained from young adults neonatally injected with all8 were tolerant 
(8). Thus, 0tH8 appears  to have comparable effects on adult A/He mice  and neonatal BALB/c mice. 
Presumably, the  reversible  suppression  observed  in adult  BALB/c  mice  is  due  to  the  high  levels of 
circulating idiotype and the relatively large numbers of cells responsive to PC, which must reduce both the 
concentration and duration of action of passively given all8. 1382  REGULATION BY COMPLEMENTARY IDIOTYPES 
actively  immunized  with  H8  or  obtained  from  normal  mice  were  transferred  to 
normal adult recipients given 300 rad. This dose of irradiation eliminates recognizable 
lymphocytes  in  bone  marrow  and  lymphoid  tissue  and  abolishes  responsivity  to 
immunization with PC for about 2 wk; recovery associated with extensive regeneration 
of lymphoid tissue is -50% at 3 wk and is complete by 4-5 wk. Therefore, mice were 
irradiated and given putative suppressor cells or pooled serum from suppressed mice; 
the  mice  were  immunized  with  PC-TNP  3-5  wk  later.  In  repeated  experiments, 
suppression  by cells was marginal  and only found when large numbers of cells were 
given; variability between mice was often great. Furthermore, NWP cells from normal 
mice usually  caused  equal  or almost  as  great  suppression  of recovery as cells  from 
mice immunized with  H8.  However, small  amounts of serum  from suppressed  mice 
containing all8 invariably suppressed recovery of the response to PC but not to TNP. 
The results combined from two experiments using the same protocol and presented in 
Table  III  reflect  the  overall  findings  for  this  series  of experiments.  Although  the 
experiments  did not exclude a  role for suppressor cells, suppression  could clearly be 
initiated  by Ig alone; therefore, the direction of the work was turned  to test  the role 
complementary Ig might play in blocking or neutralizing regulation by all8. 
Protection from  Suppression.  Both  antibody  (IgM  or  IgG)  to  an  antigen  and  the 
complementary antibody are potent, specific immunosuppressants when given several 
days before or 24 h after active immunization of animals that have not been previously 
immunized with the antigen  (53). To test the separate and combined effects that the 
complementary  immunoglobulins  aPC  and  all8  might play in  regulation,  doses of 
each that caused comparable suppression were arbitrarily selected.  Doses of aPC (0.2 
ml,  1:2 or 1:4) and all8  (0.2 ml,  1:4 or 1:8) each caused >50 but <100% suppression 
when  given  alone  1 d  before or at  the time of immunization  with  PC.  In different 
experiments,  mice given all8 were injected separately with aPC either on the same 
day or  1 d  later;  the  mice were actively immunized with  PC  either  1 or  7  d  after 
receiving aPC. 
The results  (Table IV) demonstrate that aPC prevented suppression  produced by 
all8  and  vice  versa.  Presumably  the  complementary  antibodies  neutralized  each 
other so that neither caused suppression. The effect of aPC in preventing suppression 
was  specific  to  the  extent  that  neither  normal  BALB/c  serum  absorbed  on  PC- 
Sepharose  (0.2  ml of undiluted  serum/mouse)  nor IgA (non-PC-reactive)  produced 
by the plasmacytoma MOPC315  (M315; 0.2 ml) containing 0.2 mg purified protein/ 
TABLE III 
Suppression by Cells or Complementary Idiotype Given Passively to X-irradiated Recipients 
NWP cells or antibody*  aPC PFC/spleen:[: 
None  11,800 (4.07 ± 0.34) 
Normal cells  5,200 (3.71 ± 0.35) 
H8-immunized cells  2,200 (3.34 ± 0.80) 
all8 antibody  900 (2.95 ± 0.45) 
* The results for two comparable experiments have been combined; each combined group contained seven 
or eight mice. Recipients received 300 tad 2 h before receiving 5 ×  107 cells or 0.2 ml of serum pooled 
from immunized donors. All mice were immunized with PC 3 wk later. 
:~ The difference between groups receiving no cells or all8 antibody was significant, P ~ < 0.01. However, 
the differences between groups receiving no cells or normal cells, or normal cells and H8 immunized cells 
were not significant. The mean number of PFC/spleen  for four unirradiated  normal mice was 21,000 
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Day 0*  Day 7  Day l 1:[: 
Challenge immuniza-  etPC PFC/spleen  all8  aPC  tion 
0  0  PC-TNP  21,000 (4.32 + 0.21) 
+  0  PC-TNP  3,400 (3.53 :l::  0.35) 
0  +  PC-TNP  7,200 (3.86 + 0.31) 
+  +  PC-TNP  23,400 (4.37 ± 0.26) 
* Each group contained four or five mice; all8 (0.2 ml, 1:4) and/or aPC (0.2 ml, 1:2) were given 7 d before 
challenge immunization. 
Differences in responses between groups receiving either ~tH8 or aPC alone and untreated  mice or mice 
receiving both ctH8 and ~xPC were significant, P = < 0.05. The mean numbers of aTNP PFC/spleen for 
the groups were 62,000, 66,000, 82,000, and 68,000, respectively. 
mouse) prevented suppression caused by etH8 (data not shown). Thus, the results for 
these  controls  were  consistent  with  previous  findings  that  showed  that  reciprocal 
regulation of the t~PC response by all8 was specific and not caused by immunization 
with M315  (12). Also, the experiment  was repeated,  except that 0.3 ml whole A/He 
anti-PC  serum  was  substituted  for ctPC;  the  antiserum  was  as  effective  as aPC  in 
preventing suppression by all8. 
In other experiments,  it was shown that treatment with aPC permitted recovery of 
the H8  (T15)  idiotype rather than permitting or promoting expression of a  different 
idiotype.  For  example,  10  mice were suppressed  by  giving all8  (0.2  ml,  1:4  given 
twice 1 wk apart). Five of the suppressed mice and five normal mice were treated with 
ctPC (0.2 ml, 1:2 given once a week for 3 wk, beginning 1 wk after the second injection 
of all8). All 15 mice were challenged with PC and TNP 4 wk after the treatment was 
completed.  The long interval  between  suppression  and challenge permitted  compa- 
rable recovery of total responses to PC with means of:  16,800  (4.23  +  0.025),  13,200 
(4.12 ±  0.21), and  18,000 (4.26 ±  0.18)  PFC/spleen for the three groups; however, all 
five suppressed but untreated mice had <10% PFC of T15 idiotype, whereas all mice 
in the other two groups had >50%  PFC of T15 idiotype with means of 73 and 65% 
PFC of T15 idiotype for these groups. The three groups had comparable responses to 
TNP. 
The effect  of treatment  with  aPC  was tested  next  on  mice suppressed  by giving 
all8  at the time of sublethal  irradiation,  a  procedure that can cause prolonged and 
profound  suppression  (Table  III).  Mice  were  irradiated  with  300  rad  and  injected 
with all8 on the same day. Mice were treated with aPC given either  1, 3, and 5 or 7, 
9, and  11 d  after irradiation.  In different experiments,  mice were actively immunized 
with  PC 3-5 wk after irradiation.  Although the magnitude of responses  in  different 
experiments varied depending on dosages of all8 and aPC and the interval between 
treatment  and  challenge,  the  essential  finding  demonstrated  for  one  experiment 
(Table V) was consistent; i.e., treatment with ~xPC promoted recovery of responsivity 
to  PC.  Because  sublethal  irradiation  with  300  rad  reduces  the  total  number  of 
lymphocytes in the bone marrow and spleen to <5% and the number of pre-B cells to 
<1% of normal  (54; and Ms. Deborah Dessner, personal communication), all8 given 
after irradiation  presumably tolerizes regenerating  immature cells responsive to PC, 
and treatment  with (~PC prevents this. 1384  REGULATION  BY  COMPLEMENTARY  IDIOTYPES 
TABLE V 
Treatment with aPC Promotes Recovery  from Suppression Caused by Irradiation and Complementary 
Idiotype 
Day 0*  Days 7-11  Day 35  Day 39:1: 
Irradiation  Challenge immuni-  all8  aPC  aPC PFC/spleen  (300 rad)  zation 
+  0  0  PC-TNP  27,800 (4.44 + 0.41) 
+  +  0  PC-TNP  8,600 (3.93:1: 0.24) 
+  0  +  PC-TNP  6,000 (3.78 ± 0.18) 
+  +  +  PC-TNP  28,200 (4.45 ± 0.38) 
* Each group contained five or six mice. all8 (0.2 ml, 1:4) was given on the day of irradiation, and aPC 
(0.2 ml whole) was given 7, 9, and 11 d after irradiation. Mice were challenged with PC-TNP 35 d after 
irradiation. 
:]: Differences in responses between groups receiving either all8 or aPC alone, and untreated mice or mice 
receiving both all8 and aPC were significant, P -- < 0.05. The mean numbers of aTNP PFC/spleen for 
the groups were 62,000, 74,000, 83,000, and 156,000, respectively. 
Rescue from  Suppression.  In  the  above  experiments,  treatment  with  aPC  alone 
prevented  suppression  or promoted recovery of mice given all8  passively. We next 
attempted rescue in mice made unresponsive by active immunization with H8. 
Using mice immunized with H8  1-3 mo previously, the variables tested included: 
(a) sublethal irradiation alone, (b) treatment with aPC alone, (c) combined treatment 
with  irradiation and aPC,  and  (d)  varying amounts of aPC  used for treatment  and 
intervals between  treatment  and  challenge  immunization.  X-irradiation alone  was 
not  effective, which  was  not  surprising because  circulating all8  actively produced 
before  x-irradiation  should  have  had  the  same  effect  of  tolerizing  regenerating 
lymphocytes as all8  given passively to normal sublethally irradiated mice (see above 
experiments).  Also, treatment  with  aPC  alone was  ineffective, although  this  might 
not have been the case if larger doses of aPC  (> 1.5  ml total) had been  used and/or 
the  interval  between  beginning treatment  and  challenge immunization  was  longer 
(>5 wk). 
Rescue was observed only in mice that  were irradiated and treated with amounts 
of aPC  that produced serum levels approximating those obtained with active immu- 
nization.  Rescue was not  demonstrable at 2 wk and was only partial at 4-5 wk.  For 
example, in one experiment,  18  mice to be tested were  immunized with all8  1 mo 
earlier;  six  were  irradiated  and  injected  with  0.5  ml  of aPC  1,  3,  and  5  d  after 
irradiation, six were irradiated only, and six received aPC  only. Three groups of six 
normal  control  mice  were  treated  similarly.  5  wk  after  irradiation,  all  mice  were 
challenged with PC-TNP.  The six test mice irradiated and treated with aPC  had  a 
mean  of 2,300  (3.36:1:  0.82)  PFC/spleen  to  PC;  all  12  test  mice  in  the  other  two 
groups had <200  PFC/spleen. Irradiation and/or treatment with aPC  had no affect 
on  responses  to  PC  of the  three  groups  of normal  control  mice.  All  groups  had 
comparable  responses  to  TNP.  These  findings  were  confirmed  in  two  additional 
experiments of similar design. 
To  augment  recovery, mice actively immunized with  H8 were irradiated, treated 
with  aPC,  injected  with  PC  at  1  mo,  and  with  PC-TNP  for  the  final  challenge 
immunization  at  2  too.  The  results  presented  in  Table  VI  show  almost  complete 
recovery of response to PC  in mice treated with  aPC;  furthermore,  40%  of PFC  of DONALD  A.  ROWLEY,  PAUL GRIFFITH,  AND  INGRID  LORBACH  1385 
TABLE VI 








X-irradiation  Treat-  Challenge im- 
(300 rad)~:  ment§  mmunizationll  PFC/spleen  Tt5  PFC T15 
idiotype  idiotype 
% 
+  None  PC-TNP  12,600 (4.10 ±  0.12)  28  3,529 
+  None  PC-TNP  1,200 (3.08 ±  0.38)  0  -- 
+  ~tPC  PC-TNP  8,000 (3.90 ±  0.29)  40  3,200 
* Each group contained four mice. 
:1: Irradiation was given 2 wk after active immunization. 
§ Each  treated  mouse received  five intraperitoneal  injections of 0.5  ml of aPC  given every other  day 
beginning 2 d  after irradiation, aPC was diluted  1:4 for the first injection,  1:2 for the second and third 
injections, and was used whole for the fourth and fifth injections. 
[I All mice were immunized with PC  1 mo after irradiation and with PC-TNP 2 mo after irradiation. 
¶ The difference in response between the actively immunized group not treated with PC and either other 
group was significant, P  =  <  0.05. The mean numbers of aTNP PFC/spleen for the groups were 93,000, 
85,000, and 105,000, respectively. 
suppressed  mice  treated  with  ~PC  were  of TI5  idiotype,  again  indicating  that 
treatment with ctPC (T15 idiotype) permitted recovery of the T15 idotype. 
Discussion 
Precise and specific regulation of immunity is a common objective in experimental 
and clinical immunology. Evidence for regulation usually depends on demonstrating 
specific suppression caused by antigen, lymphocytes, or the products of the immune 
response. In different models, the mediators of regulation may act directly on effectors 
or indirectly through suppression of helper activity. We failed to find consistent or 
impressive differences between suppressor function of cells obtained from suppressed 
or normal  mice. Certainly our findings do not  exclude a  role for T  suppressor  (or 
absence of T  helper) and/or accessory cells in causing or sustaining suppression, but 
apparently Ig can initiate whatever mechanism is ultimately responsible for suppres- 
sion, including direct inactivation of B cells without involvement of T  cells (28, 55). 
Because  all8  continues  to  circulate  at  appreciable  titer  for  many  months  after 
immunization  with  H8, Ig alone may sustain  suppression.  There is  the  additional 
possibility that  the all8 that effectively eliminates complementary B cells may also 
inactivate or eliminate complementary T  helper or suppressor ceils. In support of this 
possibility,  all8  injected  into  BALB/c  mice eliminated  or  inactivated  PC-specific 
helper cells (39). 
Termination of suppression  presumably occurs because the  suppressor  system  is 
exhausted or is eliminated. X-irradiation may reduce, at least temporarily, lympho- 
cytes involved in suppression;  x-irradiation may also stimulate  proliferation of the 
suppressed,  as  well  as  nonsuppressed,  clones  during  the  massive  regeneration  of 
lymphoid tissue that occurs after sublethal irradiation (56). Antibody given passively 
during the phase of rapid regeneration may have the additional effect of neutralizing 
complementary antibody and tolerizing or eliminating regenerating lymphocytes that 
bear complementary receptors. 
The condition of immunologic unresponsiveness must be a function of not only the 
state of the suppressor system but also of the state of the suppressed clones. If the rate 1386  REGULATION BY COMPLEMENTARY IDIOTYPES 
of regeneration of a clone is slow, taking many weeks or months, the current state of 
the  suppressor  system  may  not  be  relevant  to  understanding  critical  events  that 
depleted mature responsive cells earlier. For example, it requires several months for 
either neonatal liver cells or spleen cells from mice made neonatally tolerant to PC to 
restore the response to PC of either heavily irradiated syngeneic recipients or unirra- 
diated genetically unresponsive NBFa males, although both kinds of recipients support 
an aPC response of normal spleen cells on adoptive transfer (57, 58). Similarly, several 
months were required for Ig- stem cells prepared from BALB/c spleens to establish 
responsivity to  PC  in  NBF1  mice  (59).  As  far  as  we  know,  the  limiting  factor in 
restoring  or  establishing  these  responses  in  x-irradiated  or  NBF1  recipients  is  the 
inherent slow rate of maturation of B cells from stem cells rather than the absence of 
idiotype-specific helper cells  (20, 60) or other reactants that  may be required for B 
cells to mature and respond. 
Immature B cells in general are made tolerant more readily than mature B cells 
(43-47) with the provision that differences also exist between subpopulations (48, 49, 
51,  52).  Under usual  circumstances, immature B  cells specific for self antigens  are 
presumably  eliminated,  whereas  the  remaining  clones  mature.  Under  appropriate 
conditions of antigen stimulation, mature B cells proliferate, differentiate, synthesize, 
and secrete Ig. The Ig secreted may then serve to protect the clone in two ways:  (a) 
by tolerizing complementary clones, and (b) by protecting immature cells of the clone 
from tolerization by persisting antigen or complementary reactants if they are present. 
It  is  possible  that  analogous  events  occur  when  mature  B  cells  in  the  adult  are 
eliminated and clones are regenerated from stem cells. 
Clearly, mature and immature B cells can be made tolerant by sufficient amounts 
of complementary antibody actively produced or passively given. Once mature cells 
are eliminated, Ig of the specificity produced by the clone will be absent or disappear. 
We assumed,  therefore, that  recovery of a  suppressed clone required replenishment 
from stem or precursor cells and, in the absence of protective Ig, the maturing cells 
may be made tolerant by persisting antigen and/or complementary reactants so that 
tolerance is perpetuated. In any event, these considerations were consistent with our 
previous and present observations, which show the role of complementary antibodies 
in  causing  or  preventing suppression,  depending  on  the  sequence  of their  action. 
These considerations  also  provided  the  rationale  for giving  Ig  passively to  rescue 
responses already suppressed. 
There is presumably a  selective advantage for having immune responses to infec- 
tious or noxious agents that are not suppressed prematurely or inappropriately. The 
early production of IgM may help serve this function. Although either antibody or 
the complementary antibody is a potent and specific immunosuppressant when given 
at the time of primary immunization in vivo or in vitro (53, 61-63), the role of actively 
produced antibodies in the homeostasis of ongoing immune responses remains, in our 
opinion, poorly understood. It is possible that only in the absence of an early and/or 
vigorous antibody response does a  first immunization stimulate a complementary or 
anti-idiotypic response that is effective in regulating the first response. For example, 
contact hypersensitivity produced in mice by skin painting with dinitrofluorobenzene 
(DNFB)  is  apparently limited  in  severity and  duration  by autogenously produced 
anti-idiotypic antibody (36); interestingly, the procedure used to induce delayed-type 
hypersensitivity in these experiments does not result in detectable circulating antibody DONALD A.  ROWLEY, PAUL GRIFFITH, AND INGRID LORBACH  1387 
to  DNFB  (Dr.  Henry  Claman,  personal  communication).  Specific  T  blast  cells 
stimulated  by DNFB  may initiate the  anti-idiotypic response, a  suggestion  that  is 
compatible with the demonstration that T  blast cells selected for in culture can be 
used as antigen to stimulate an anti-idiotypic response in a  normal host (18, 64). In 
another experimental model, autogenously produced anti-idiotypic antibody appar- 
ently causes feedback suppression of the antibody response of mice to TNP-Ficoll (32, 
34, 35), but mice have only about  10% as high levels of antibody to the antigen as 
mice  immunized  with  TNP  coupled  to  more  conventional carriers  (Dr.  Edmond 
Goidl, personal communication). In this instance, autogenous B or T  blast cells may 
be effective immunogens for stimulating complementary B lymphocytes in the absence 
of early appreciable circulating aTNP antibody. 
Absent or suppressed immunity can be rectified by adoptive transfer of appropriate 
syngeneic cells in some experimental models, but for outbred individuals, it may be 
more reasonable to attempt rescue from autogenous stem cells rather than create a 
chimera. The present studies suggest that passively given antibody may be used as a 
specific reagent for aiding in the rescue of clones having the same specificity as the 
passively given antibody. It seems likely from experimental observations and theoret- 
ical  considerations  discussed  that  sublethal  x-irradiation  or other  procedures  that 
destroy mature lymphocytes will be a useful or necessary adjunct. 
Surflmary 
A/He mice actively producing complementary or anti-idiotypic antibody directed 
against  a  combining site structure for phosphorylcholine (PC)  have profound and 
long-lasting suppression of their response to PC. B cells from unresponsive mice are 
unresponsive in vitro, and attempts to demonstrate suppressor cells in unresponsive 
mice were unsuccessful. Although the process ultimately responsible for suppression 
has not been defined, suppression can be initiated by anti-idiotypic antibody alone 
and  prevented  by  complementary  Ig;  i.e.,  by  anti-PC  antibody.  Furthermore,  a 
suppressed  anti-PC  response  can  be  rescued by sublethal  irradiation  and  anti-PC 
antibody  given  passively.  The  recovery  of  the  suppressed  response  is  slow  and 
presumably  results  from  maturation  from  "stem" cells,  which  are  protected  from 
tolerization  by  the  passively  given  antibody.  Thus,  by  extrapolation,  one  of the 
functions of secreted Ig may be to protect the clone that produces it. 
Received  for publication 17 November 1980 and in revised  form 3 February 1981. 
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